A Phase 2 Multi-Center, Open Label Study to Assess the Safety, Efficacy and Pharmacodynamics of IMG-7289 in Patients with Essential Thrombocythemia

Project: Research

Project Details

StatusFinished
Effective start/end date21/08/20 → 20/08/25

Keywords

  • clinical trial
  • treatment efficacy
  • treatment safety
  • phase 2 study

Clinical Trial Phase

  • Phase II